Argenx price target raised to $660 from $540 at Truist

Truist raised the firm’s price target on Argenx (ARGX) to $660 from $540 and keeps a Buy rating on the shares. The firm notes Q3 delivered 11th consecutive quarter-over-quarter growth with net sales of $573M vs its $529M and Street’s $514M. Most importantly, in Truist’s view, Argenx has the most enviable I&I pipeline in the industry with multiple data read-outs over the next 12-18 months.